Keywords: Monoclonal antibody; Novel agents; Radioimmunotherapy; Transformed lymphoma; Treatment outcome;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Melanoma; Radiotherapy; Dose hypofractionation; Radioimmunotherapy; Heavy ion radiotherapy;
Keywords: Bortezomib; BTK; Clinical trial; Copanlisib; Ibritumomab tiuxetan; Ibrutinib; Idelalisib; Lenalidomide; Marginal zone lymphoma; Obinutuzumab; PI3K; Radioimmunotherapy; Rituximab; TGR-1202; Ublituximab; Venetoclax;
Keywords: Astatine-211, 211At; Cyclotron target; Radioimmunotherapy; Targeted alpha therapy; Laboratory automation; Bismuth metal dissolution;
Keywords: Monte Carlo; Cellular dosimetry; I-125; Radioimmunotherapy;
Keywords: Indolent lymphoma; Nonmyeloablative transplantation; Radioimmunotherapy
Keywords: Elderly; Indolent NHL; Quality of life; Radioimmunotherapy; Safety
Keywords: cost-effectiveness; follicular lymphoma; lymphoma; maintenance; non-Hodgkin lymphoma; radioimmunotherapy; rituximab;
Keywords: CaTSiT; cancer and treatment simulation tool; EBRT; external beam radiation therapy; MIRD; Medical Internal Radiation Dose; XML; Extensible Markup Language; XSD; XML Schema Definition; Computer simulation; Metastasis; Radiotherapy; Radioimmunotherapy; Rad
Keywords: Radioimmunotherapy; Zevalin; Z-BEAM
Keywords: Targeted alpha therapy; La antigen; Monte Carlo simulations; Radioimmunotherapy; Hypoxia;
Keywords: Pegylated Liposomes; Radioimmunotherapy; Bispecific Antibody; Pretargeting; Biacore;
Keywords: α Particles; β electrons; radioimmunotherapy; targeted radiotherapy; vectors;
Keywords: Radioimmunotherapy; Iodine-131 tositumomab; Yttrium-90 ibritumomab tiuxetan; Follicular lymphoma; Diffuse large B-cell lymphoma
Keywords: SPECT; Molecular imaging; Radioiodine; Radioimmunotherapy
Evaluation of 177Lu[Lu]-CHX-Aâ³-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII
Keywords: Glioblastoma; Fab; Carbonic anhydrase XII; Radioimmunotherapy; 177Lu;
212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models
Keywords: Radioimmunotherapy; Pancreatic ductal adenocarcinoma; 212Pb; B7-H3;
Radiopharmaceutical enhancement by drug delivery systems: A review
Keywords: Nuclear medicine; Drug carrier systems; Radiopharmaceuticals; Theranostics; Multi-modality imaging; ALARA; As Low As Reasonably Achievable; BMEDA; N,N-bis [2-mercaptoethyl]-Nâ²,Nâ²-diethylethylenediamine; CLI; Cerenkov luminescence imaging; CT; Computed
Novel Immunotherapy Approaches in AML: Focus on Monoclonal Antibodies
Keywords: Acute myeloid leukemia; Target antigens; Bispecific antibodies; Antibody-drug conjugates; Radioimmunotherapy;
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Keywords: Allogeneic transplantation; Reduced-intensity conditioning; Radioimmunotherapy; B cell lymphoma; Clinical trial;
Radioimmunotherapy for non-Hodgkin's lymphoma: positioning, safety, and efficacy of 90Y-ibritumomab. 10 years of experience and follow-up
Keywords: Lymphoma; Non-Hodgkin; Radioimmunotherapy; Ibritumomab; Linfoma; No Hodgkin; Radioinmumoterapia; Ibritumomab;
AutologousPhase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology
Keywords: Zevalin; BEAM; 90yttrium-ibritumomab tiuxetan; Radioimmunotherapy; Autologous stem cell transplantation;
Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons
Keywords: Radioimmunotherapy; α-Particles; Auger electrons; Radiation treatment; Monoclonal antibodies; Cancer;
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma
Keywords: CAIX; Clear cell renal cell carcinoma; Girentuximab; Radioimmunotherapy;
Targeted therapy of osteosarcoma with radiolabeled monoclonal antibody to an insulin-like growth factor-2 receptor (IGF2R)
Keywords: OS; Radioimmunotherapy; Insulin-like growth factor-2 receptor (IGF2R); Rhenium-188;
Original StudyCHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma
Keywords: Bexxar; Consolidation therapy; DLBCL; Radioimmunotherapy;
Auger electron-emitting 111In-DTPA-NLS-CSL360 radioimmunoconjugates are cytotoxic to human acute myeloid leukemia (AML) cells displaying the CD123+/CD131â phenotype of leukemia stem cells
Keywords: Acute myeloid leukemia (AML); Radioimmunotherapy; Indium-111; CD123; Auger electrons; Nuclear translocation sequences (NLS);
Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response
Keywords: Radioimmunotherapy; Non-Hodgkin's lymphoma; Prediction of response; Assessment of response; Patient selection; Prognostic factors; Imaging; Risk assessment;
A pioneer experience in Malaysia on In-house Radio-labelling of 131I-rituximab in the treatment of Non-Hodgkin's Lymphoma and a case report of high dose 131I-rituximab-BEAM conditioning autologous transplant
Keywords: Radioimmunotherapy; 131I-rituximab; Iodine-131; Rituximab; Non-Hodgkin's lymphoma;
Preclinical evaluation of a diabody-based 177Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model
Keywords: CD22; Diabody; Lymphoma; Radioimmunotherapy; Dual-targeting; PEGylationAUC, area under the curve; BLI, bioluminescence imaging; B-NHL, B-cell non-Hodgkin lymphoma; CHX-A″-DTPA, N-[(R)-2-amino-3-(p-isothiocyanato-phenyl)propyl]-trans-(S,S)-cyclohexane-1,2-
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal 90Y
Keywords: Yttrium-90; Trastuzumab; CHX-A″-DTPA; H4octapa; Radiometal; Radioimmunotherapy
REVIEWRadioimmunotherapy-based conditioning for hematopoietic stem cell transplantation: Another step forward
Keywords: Radioimmunotherapy; Hematopoietic stem cell transplantation; Beta emitters; Alpha emitters; Pre-targeting; Acute myeloid leukemia; Lymphoma; Multiple myeloma;
Zevalin® (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned?
Keywords: Zevalin; Ibritumomab tiuxetan; Non-Hodgkin's lymphoma; Radioimmunotherapy;
Consolidation of first remission using radioimmunotherapy with yttrium-90-ibritumomab-tiuxetan in adult patients with Burkitt lymphoma
Keywords: Burkitt lymphoma; Yttrium-90-ibritumomab-tiuxetan; Zevalin; Radioimmunotherapy; Rituximab
131I-Nimotuzumab - A potential radioimmunotherapeutic agent in treatment of tumors expressing EGFR
Keywords: Radioimmunotherapy; 131I-Nimotuzumab; EGFR; Head and neck cancer;
90Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapies
Keywords: Pancreatic cancer; Radioimmunotherapy; Clivatuzumab tetraxetan; Gemcitabine; Antibody; Yttrium-90;
Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of 90Y and 177Lu
Keywords: Bifunctional ligands; Y-90; Lu-177; Radioimmunotherapy;
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapy
Keywords: Radioimmunotherapy; Alpha particle; Bismuth-213; Oncology: multiple myeloma; CD138; Melphalan;
Radiolabeled Anti-CD45 Antibody with Reduced-Intensity Conditioning and Allogeneic Transplantation for Younger Patients with Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Keywords: Radioimmunotherapy; Acute myeloid leukemia; Myelodysplastic syndrome; Hematopoietic cell transplantation; Anti-CD45 antibody; Iodine-131
Myeloablative I-131-Tositumomab with Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years with B Cell Lymphoma
Keywords: B cell lymphoma; Radioimmunotherapy; Autologous; Elderly
The human polynucleotide kinase/phosphatase (hPNKP) inhibitor A12B4C3 radiosensitizes human myeloid leukemia cells to Auger electron-emitting anti-CD123 111In-NLS-7G3 radioimmunoconjugates
Keywords: Acute myeloid leukemia; Auger electrons; Indium-111; Radioimmunotherapy; CD123; Leukemia stem cells;
MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+/CD131− epitope expressed by leukemia stem cells
Keywords: CD123; MicroSPECT/CT; Leukemia stem cells; NOD/SCID mouse; Radioimmunotherapy
Radioiodinated and astatinated NHC rhodium complexes: Synthesis
Keywords: NHC; N-heterocyclic carbene; DIPE; Diisopropyl ether; SAB; Succinimidyl astatobenzoate; FAb; Fragment of antibody; THF; Tetrahydrofurane; COD; cyclooctadiene; FD/FI; Field desorption/field ionization; RT; Room temperature; RCY; Radiochemical yield; RCP; R
Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential
Keywords: Radioimmunotherapy; Radiotherapy; Epidermal growth factor receptor (EGFR) inhibition; Combined treatment; Cetuximab;
213Bi-anti-EGFR radioimmunoconjugates and X-ray irradiation trigger different cell death pathways in squamous cell carcinoma cells
Keywords: Head and neck squamous cell carcinoma; α-emitter 213Bi; Radioimmunotherapy; UD-SCC5 cells; Cytotoxicity; Cell-cycle arrest; Apoptosis
DNA damage-centered signaling pathways are effectively activated during low dose-rate Auger radioimmunotherapy
Keywords: Radioimmunotherapy; Auger electrons; Signaling pathways; DNA damage; 125I-mAbs;
Apoptosis and p53 are not involved in the anti-tumor efficacy of 125I-labeled monoclonal antibodies targeting the cell membrane
Keywords: Radioimmunotherapy; Auger electrons; p53; Apoptosis; 125I-mAbs;
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor o
Keywords: Targeted alpha-therapy; Radioimmunotherapy; Alpha-emitter; Bismuth-213; Anti-CD33-antibody; Acute myeloid leukaemia; Cancer; Radioresistance; Chemoresistance;
Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy
Keywords: Melanoma; Cancer stem cells; Radioimmunotherapy; Clinical trial; Melanin
Phase II Trial of 131-Iodine Tositumomab with High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed Diffuse Large B Cell Lymphoma
Keywords: Radioimmunotherapy; Autologous stem cell transplantation; Diffuse large B cell lymphoma; 131-Iodine tositumomab